| 1 |
34857478 | Elevated CD19+Siglec-10+ B cell levels are correlated with systemic lupus erythematosus disease activity. | 2022 Jan |
1 |
| 2 |
33223341 | A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides. | 2021 Jan |
1 |
| 3 |
33996901 | Terminal Epitope-Dependent Branch Preference of Siglecs Toward N-Glycans. | 2021 |
1 |
| 4 |
29997173 | CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function. | 2018 Jul 24 |
1 |
| 5 |
25280627 | Molecular characterization of porcine Siglec-10 and analysis of its expression in blood and tissues. | 2015 Jan |
1 |
| 6 |
25320078 | Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs. | 2014 Nov 28 |
1 |
| 7 |
23038623 | Click and pick: identification of sialoside analogues for siglec-based cell targeting. | 2012 Oct 29 |
1 |
| 8 |
11284738 | Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. | 2001 Apr 15 |
1 |
| 9 |
11358961 | Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells. | 2001 Jul 27 |
3 |